HIF1A and breast cancer: These results suggest that β2M silencing downregulated p-SGK1/SGK1 levels and Bcl-2 expression, but did not affect the HER2, HIF-1α, VEGF and ERK signaling in ER+ breast cancer cells with HER2−.